NCT02509429View on ClinicalTrials.gov

Comparison of an Artificial Pancreas Versus Threshold Low Glucose Suspend in Type 1 Diabetic Children

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 16, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Type 1 Diabetes
Interventions
DEVICE

Insulin therapy (aspart, lispro ou glulisine) with Control-to-Range algorithm

The insuline used is usual patient insuline. There is no specific insulin for this protocol

DEVICE

Insulin therapy ((aspart, lispro ou glulisine) withThreshold Low Glucose Suspend

The insuline used is usual patient insuline. There is no specific insulin for this protocol

Trial Locations (4)

34985

CHU Montpellier - Hôpital Lapeyronie, Montpellier

37000

CHU de Tours, Hôpital Clocheville, Tours

49000

CHU d'Angers, Angers

75019

AP-HP, Hôpital Robert Debré, Paris

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT02509429 - Comparison of an Artificial Pancreas Versus Threshold Low Glucose Suspend in Type 1 Diabetic Children | Biotech Hunter | Biotech Hunter